Adaptive Biotechnologies Corporation (ADPT)

NASDAQ: ADPT · Real-Time Price · USD

Compare

16.04

+0.50 (3.22%)

At close: Feb 13, 2026, 4:00 PM EST

16.15

+0.11 (0.69%)

After-hours: Feb 13, 2026, 7:09 PM EST

Adaptive Biotechnologies Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	276.98	178.96	170.28	185.31	154.34
Revenue Growth (YoY)	54.77%	5.10%	-8.11%	20.06%	56.88%
Cost of Revenue	165.13	175.03	197.67	199.67	191.64
Gross Profit	111.85	3.92	-27.39	-14.36	-37.3
Selling, General & Admin	167.27	157.57	172.51	184.13	169.97
Amortization of Goodwill & Intangibles	1.7	1.7	1.7	1.7	1.7
Operating Expenses	168.97	159.27	174.21	185.83	171.67
Operating Income	-57.12	-155.34	-201.61	-200.19	-208.97
Interest Expense	-11.78	-11.58	-13.8	-4.24	-
Interest & Investment Income	9.44	6.33	6.35	4.8	8.9
EBT Excluding Unusual Items	-59.46	-160.6	-209.06	-199.63	-200.07
Merger & Restructuring Charges	-	-7.21	-	-	-
Gain (Loss) on Sale of Investments	-	8.21	9.18	-0.74	-7.23
Asset Writedown	-	-	-25.43	-	-
Pretax Income	-59.46	-159.6	-225.3	-200.37	-207.3
Earnings From Continuing Operations	-59.46	-159.6	-225.3	-200.37	-207.3
Minority Interest in Earnings	-0.04	0.1	0.05	0.18	0.02
Net Income	-59.5	-159.49	-225.25	-200.19	-207.28
Net Income to Common	-59.5	-159.49	-225.25	-200.19	-207.28
Shares Outstanding (Basic)	152	147	144	143	140
Shares Outstanding (Diluted)	152	147	144	143	140
Shares Change (YoY)	3.14%	1.88%	1.31%	1.54%	6.96%
EPS (Basic)	-0.39	-1.08	-1.56	-1.40	-1.48
EPS (Diluted)	-0.39	-1.08	-1.56	-1.40	-1.48
Free Cash Flow	-	-98.88	-167.02	-200.29	-254.47
Free Cash Flow Per Share	-	-0.67	-1.16	-1.41	-1.81
Gross Margin	40.38%	2.19%	-16.09%	-7.75%	-24.17%
Operating Margin	-20.62%	-86.80%	-118.40%	-108.03%	-135.39%
Profit Margin	-21.48%	-89.12%	-132.28%	-108.03%	-134.30%
Free Cash Flow Margin	-	-55.25%	-98.09%	-108.09%	-164.87%
EBITDA	-38.94	-136.09	-179.38	-179.27	-195.01
EBITDA Margin	-14.06%	-76.05%	-105.34%	-96.74%	-126.35%
D&A For EBITDA	18.18	19.26	22.23	20.92	13.95
EBIT	-57.12	-155.34	-201.61	-200.19	-208.97
EBIT Margin	-20.62%	-86.80%	-118.40%	-108.03%	-135.39%
Advertising Expenses	-	6.1	8.6	13.7	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q